NKT cell stimulation with α-galactosylceramide results in a block of Th17 differentiation after intranasal immunization in mice

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Zygmunt, Beata M ^a,b   Weissmann, Sebastian F ^a   Guzman, Carlos A ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; OVALBUMIN; ALPHA-GALACTOSYLCERAMIDE; GALACTOSYLCERAMIDE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL SEPARATION; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; EVALUATION; IMMUNIZATION; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; METHODOLOGY; MOUSE MUTANT; PHYSIOLOGY;

MUS;

ADMINISTRATION, INTRANASAL; ANIMALS; CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; DOWN-REGULATION; GALACTOSYLCERAMIDES; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; TH17 CELLS;

EID: 84856252999     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030382     Document Type: Article

References (27)

1. Kronenberg M, Gapin L, (2002) The unconventional lifestyle of NKT cells. Nat Rev Immunol 2: 557-568.
2. Cerundolo V, Silk JD, Masri SH, Salio M, (2009) Harnessing invariant NKT cells in vaccination strategies. Nat Rev Immunol 9: 28-38.
3. Yoshimoto T, Bendelac A, Watson C, Hu-Li J, Paul WE, (1995) Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production. Science 270: 1845-1847.
4. Miyamoto K, Miyake S, Yamamura T, (2001) A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413: 531-534.
5. Singh AK, Wilson MT, Hong S, Olivares-Villagomez D, Du C, et al. (2001) Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 194: 1801-1811.
6. Steinman L, (2007) A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13: 139-145.
7. Mars LT, Araujo L, Kerschen P, Diem S, Bourgeois E, et al. (2009) Invariant NKT cells inhibit development of the Th17 lineage. Proc Natl Acad Sci U S A 106: 6238-6243.
8. Oh K, Byoun OJ, Ham DI, Kim YS, Lee DS, Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation. Eur J Immunol 41: 392-402.
9. Michel ML, Keller AC, Paget C, Fujio M, Trottein F, et al. (2007) Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 204: 995-1001.
10. Coquet JM, Chakravarti S, Kyparissoudis K, McNab FW, Pitt LA, et al. (2008) Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population. Proc Natl Acad Sci U S A 105: 11287-11292.
11. Rachitskaya AV, Hansen AM, Horai R, Li Z, Villasmil R, et al. (2008) Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol 180: 5167-5171.
12. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM, (2003) Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 198: 267-279.
13. Ko SY, Ko HJ, Chang WS, Park SH, Kweon MN, et al. (2005) alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor. J Immunol 175: 3309-3317.
14. Ebensen T, Link C, Riese P, Schulze K, Morr M, et al. (2007) A pegylated derivative of alpha-galactosylceramide exhibits improved biological properties. J Immunol 179: 2065-2073.
15. Zygmunt BM, Rharbaoui F, Groebe L, Guzman CA, (2009) Intranasal immunization promotes th17 immune responses. J Immunol 183: 6933-6938.
16. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB, (2003) Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 4: 1230-1237.
17. Uemura Y, Liu TY, Narita Y, Suzuki M, Nakatsuka R, et al. (2009) Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells. J Immunol 183: 201-208.
18. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, et al. (2007) Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26: 371-381.
19. Park H, Li Z, Yang XO, Chang SH, Nurieva R, et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133-1141.
20. Chen H, Paul WE, (1997) Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. J Immunol 159: 2240-2249.
21. Stetson DB, Mohrs M, Reinhardt RL, Baron JL, Wang ZE, et al. (2003) Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med 198: 1069-1076.
22. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC, (2006) A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 203: 1685-1691.
23. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, et al. (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177: 566-573.
24. Nakae S, Nambu A, Sudo K, Iwakura Y, (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171: 6173-6177.
25. Nakae S, Saijo S, Horai R, Sudo K, Mori S, et al. (2003) IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci U S A 100: 5986-5990.
26. Lin Y, Ritchea S, Logar A, Slight S, Messmer M, et al. (2009) Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 31: 799-810.
27. Tupin E, Kinjo Y, Kronenberg M, (2007) The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol 5: 405-417.